Here are three key things you need to know about Medtronic that may get you to buy the stock today.

In the closing of the recent trading day, Medtronic (MDT) stood at $91.98, denoting a -1% move from the preceding trading day.

Medtronic PLC closed 4.44% short of its 52-week high of $96.25, which the company achieved on March 10th.

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This ...

FourKites®, the global leader in AI-driven supply chain transformation, today announced that Dov Shenkman, CEO and Founding ...

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026. Read more on MDT stock here.

Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

All of those factors make Medtronic an excellent pick for income-seeking investors. It should continue rewarding shareholders ...

Medtronic also disclosed severance for a former SVP, and pay for its median employee, and a slight decrease in global ...

Medtronic's separation of its Medtronic Diabetes unit into a publicly traded company named MiniMed will be a new beginning ...

Medtronic CEO Geoff Martha's pay rises 16% to $23 million as company beats expectations and plans diabetes unit spinoff.

Bearish flow noted in Medtronic (MDT) with 4,555 puts trading, or 3x expected. Most active are 8/29 weekly 91 puts and Aug-25 92.5 calls, with ...